Generic Product News

Published Online: Tuesday, August 6, 2013
Follow Pharmacy_Times:

Methylphenidate Hydrochloride Tablets

Marketed by: Caraco Pharmaceutical Laboratories
Compare to: Ritalin (Novartis)
Indication: Caraco Pharmaceutical Laboratories, a division of Sun Pharmaceutical Industries Limited, has released methylphenidate hydrochloride, a generic equivalent to Novartis’ Ritalin. It is indicated for the treatment of attention deficit disorder symptoms, including moderate to severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity. It is contraindicated in patients with marked anxiety, tension, and agitation, in patients with motor tics or a family history or diagnosis of Tourette’s syndrome, and in patients with glaucoma.
Dosage Form: Tablets: 5, 10, and 20 mg
For More Information:

My Way LevonorgestreL Tablets, 1.5 Mg
Marketed by: GAVIS Pharmaceuticals
Compare to: Plan B (Teva Pharmaceuticals)
Indication: My Way levonorgestrel tablets, 1.5 mg, was launched by GAVIS Pharmaceuticals. My Way levonorgestrel tablets are a generic equivalent to Teva’s Plan B, and are indicated to prevent pregnancy after known or suspected contraceptive failure or unprotected intercourse. Tablets should be taken orally within 72 hours of unprotected intercourse or contraceptive failure. Tablets are more effective if taken earlier within the 72-hour window.
Dosage Form: Tablets: 1.5 mg
For More Information:

Diphenhydramine Hydrochloride Injection, USP
Marketed by: BD Rx Inc
Indication: BD has released Diphenhydramine Hydrochloride Injection, USP, to launch BD Simplist, its line of prefilled generic injectable medications. It is indicated for amelioration of allergic reactions to blood or plasma, in anaphylaxis as an adjunct to epinephrine and other standard measures after the acute symptoms have been controlled, and for other uncomplicated allergic conditions of the immediate type when oral therapy is impossible or contraindicated.
Dosage Form: Injection: 50 mg/mL
For More Information:

Calcitriol Soft Gel Capsules
Marketed by: Heritage Pharmaceuticals Inc
Compare to: Rocaltrol (Hoffmann-La Roche)
Indication: Heritage Pharmaceuticals Inc announces the availability of calcitriol soft gel capsules, an AB-rated generic equivalent to Hoffmann-La Roche’s synthetic vitamin D product Rocaltrol. It is indicated for the treatment of secondary hyperparathyroidism and resultant metabolic bone disease in patients with moderate to severe chronic renal failure who are not yet on dialysis. It is also indicated for the management of hypocalcemia in patients who are undergoing dialysis.
Dosage Form: Capsules: 0.25 and 0.5 mcg
For More Information:

Related Articles
Teva and Mylan announced the US launches of their generic equivalents to Novartis’s Exforge.
An oral formulation of deferasirox is approved for the treatment of chronic iron overload due to blood transfusions.
Read about the new Rx Products featured in March.
About 17% of college students misuse stimulant medications prescribed for attention deficit hyperactivity disorder (ADHD), according to a new study published in the Clinical Child and Family Psychology Review.
Latest Issues
  • photo
    Pharmacy Times
    Health-System Edition
    Directions in Pharmacy
    OTC Guide
    Generic Supplements
  • photo
    Pharmacy Careers
    Specialty Pharmacy Times